Quantbot Technologies LP Has $950,000 Stock Holdings in Chemed Co. (NYSE:CHE)

Quantbot Technologies LP lowered its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 77.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,581 shares of the company's stock after selling 5,476 shares during the quarter. Quantbot Technologies LP's holdings in Chemed were worth $950,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in CHE. GAMMA Investing LLC boosted its stake in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company's stock valued at $47,000 after purchasing an additional 22 shares in the last quarter. American National Bank & Trust acquired a new stake in Chemed during the 3rd quarter valued at approximately $61,000. Mather Group LLC. boosted its holdings in Chemed by 60.5% in the second quarter. Mather Group LLC. now owns 183 shares of the company's stock valued at $99,000 after purchasing an additional 69 shares during the last quarter. Quarry LP grew its stake in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company's stock worth $103,000 after purchasing an additional 166 shares during the period. Finally, Sound Income Strategies LLC acquired a new position in shares of Chemed during the 3rd quarter worth approximately $201,000. 95.85% of the stock is currently owned by institutional investors.

Chemed Price Performance

Shares of NYSE CHE traded down $3.36 during trading on Monday, hitting $569.03. 45,778 shares of the company were exchanged, compared to its average volume of 85,774. The firm's fifty day moving average price is $578.27 and its 200 day moving average price is $565.05. The company has a market cap of $8.56 billion, a price-to-earnings ratio of 28.84, a PEG ratio of 2.43 and a beta of 0.46. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analysts' expectations of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the business posted $5.32 EPS. On average, research analysts forecast that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed's dividend payout ratio is presently 10.11%.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. The trade was a 1.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Spencer S. Lee sold 732 shares of the business's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now directly owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,845 shares of company stock worth $3,978,798 over the last quarter. 3.32% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CHE. Royal Bank of Canada lowered their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 5th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Saturday.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.